Physician
Family Planning Associates Medical Group INC
Family Planning Associates Medical Group INC was paid $17.23M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 18% of everything it billed.
33Billing provider infoFAMILY PLANNING ASSOCIATES MEDICAL GROUP INC
SAN BERNARDINO, CA 92408
SAN BERNARDINO, CA 92408
33aNPI1487749495assigned 10/04/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$17.23M
24GClaims240,675
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in California
Rank by total paid#4 of 791
Median peer was paid$67K
This provider vs. median258×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FELDKAMP IV, IRVING controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,784 | $2.87M | |
| 2019 | 32,025 | $2.68M | |
| 2020 | 32,471 | $2.40M | |
| 2021 | 36,675 | $2.56M | |
| 2022 | 34,713 | $2.17M | |
| 2023 | 42,435 | $2.55M | |
| 2024incomplete | 39,572 | $2.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 18% | 3,268 | 3,077 | $3.17M |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 14% | 4,640 | 4,569 | $2.34M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 8.3% | 1,559 | 1,419 | $1.44M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.6% | 21,940 | 20,530 | $1.15M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.2% | 22,791 | 22,582 | $731K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.2% | 22,745 | 22,538 | $727K |
| 58300 | 3.9% | 7,330 | 3,664 | $672K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | 3.7% | 634 | 634 | $638K |
| J3490 | Unclassified drugs | 3.6% | 17,799 | 16,244 | $621K |
| 11981 | 3.2% | 2,609 | 2,553 | $554K | |
| 59840 | 3.0% | 2,909 | 1,580 | $524K | |
| S4993 | Contraceptive pills for birth control | 3.0% | 3,211 | 3,203 | $510K |
43 more codes
| 90651 | 2.4% | 1,530 | $411K | |
| A4267 | Contraceptive supply, condom, male, each | 2.1% | 24,818 | $370K |
| S0190 | Mifepristone, oral, 200 mg | 1.9% | 5,036 | $323K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.8% | 5,880 | $317K |
| J7300 | Intrauterine copper contraceptive (paragard) | 1.5% | 323 | $262K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.5% | 3,393 | $255K |
| 87806 | 1.4% | 8,752 | $238K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 1.4% | 96 | $233K |
| 11976 | 1.2% | 3,813 | $211K | |
| J7301 | Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg | 1.2% | 286 | $211K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.2% | 2,427 | $200K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.1% | 5,905 | $194K |
| 87799 | <1% | 3,546 | $144K | |
| 58301 | <1% | 4,530 | $130K | |
| 87481 | <1% | 3,559 | $119K | |
| 01966 | <1% | 1,147 | $79K | |
| 81025 | <1% | 22,336 | $67K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 408 | $59K |
| 87563 | <1% | 1,338 | $51K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 5,171 | $43K |
| 99201 | <1% | 700 | $34K | |
| 99000 | <1% | 2,905 | $33K | |
| G9920 | Screening performed and negative | <1% | 4,645 | $32K |
| 76830 | Ultrasound, transvaginal | <1% | 393 | $27K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 812 | $22K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 5,036 | $16K |
| 11982 | <1% | 205 | $14K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 158 | $12K |
| 57454 | <1% | 196 | $11K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 853 | $11K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 81 | $8K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 380 | $5K |
| 81002 | <1% | 1,742 | $4K | |
| 85018 | <1% | 1,792 | $4K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 1,802 | $4K |
| 83986 | <1% | 1,034 | $3K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 799 | $3K |
| 87210 | <1% | 554 | $2K | |
| 76998 | <1% | 15 | $2K | |
| 86901 | <1% | 626 | $2K | |
| 99152 | <1% | 26 | $1K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 161 | $258.97 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 31 | $18.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFELDKAMP IV, IRVING (OWNER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.